{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:19:15Z","timestamp":1793643555180,"version":"4.5.1"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T00:00:00Z","timestamp":1722211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-024-03565-9","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T09:05:07Z","timestamp":1722243907000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Bridging the gap in managing dry eye disease: a consensus report by the Taiwan society of cataract and refractive surgeons"],"prefix":"10.1186","volume":"24","author":[{"given":"Chi-Chin","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiuh-Liang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Min","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Yu","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"issue":"3","key":"3565_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334\u201365.","journal-title":"Ocul Surf"},{"issue":"6","key":"3565_CR2","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/opo.12888","volume":"41","author":"EB Papas","year":"2021","unstructured":"Papas EB. The global prevalence of dry eye disease: a Bayesian view. Ophthalmic Physiol Opt. 2021;41(6):1254\u201366.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"2","key":"3565_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/NHH.0000000000000652","volume":"36","author":"PA Rouen","year":"2018","unstructured":"Rouen PA, White ML. Dry eye disease: prevalence, assessment, and management. Home Healthc Now. 2018;36(2):74\u201383.","journal-title":"Home Healthc Now"},{"issue":"5","key":"3565_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.18773\/austprescr.2018.048","volume":"41","author":"Q Findlay","year":"2018","unstructured":"Findlay Q, Reid K. Dry eye disease: when to treat and when to refer. Aust Prescr. 2018;41(5):160.","journal-title":"Aust Prescr"},{"issue":"1","key":"3565_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1120672120960586","volume":"31","author":"S Barabino","year":"2021","unstructured":"Barabino S, Aragona P, di Zazzo A, Rolando M, with the Contribution of Selected Ocular Surface Experts from the Societ\u00e0 Italiana di Dacriologia e Superficie Oculare. Updated definition and classification of dry eye disease: Renewed proposals using the nominal group and Delphi techniques. Eur J Ophthalmol. 2021;31(1):42\u20138.","journal-title":"Eur J Ophthalmol"},{"issue":"7","key":"3565_CR6","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/ijms18071398","volume":"18","author":"X Zhang","year":"2017","unstructured":"Zhang X, Jeyalatha MV, Qu Y, et al. Dry eye management: targeting the ocular surface microenvironment. Int J Mol Sci. 2017;18(7):1398.","journal-title":"Int J Mol Sci"},{"key":"3565_CR7","volume-title":"The global prevalence of dry eye disease and its association with economy: a systematic review","author":"Y Wan","year":"2019","unstructured":"Wan Y, Zhang M, Li X. The global prevalence of dry eye disease and its association with economy: a systematic review. 2019."},{"issue":"11","key":"3565_CR8","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1097\/ICO.0000000000002987","volume":"41","author":"IC Lin","year":"2022","unstructured":"Lin IC, Kuo YK, Liu HY, et al. Trends in diagnosed dry eye disease incidence, 2001 to 2015: a nationwide population-based study in Taiwan. Cornea. 2022;41(11):1372\u20137.","journal-title":"Cornea"},{"key":"3565_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ajo.2021.03.013","volume":"227","author":"N Hung","year":"2021","unstructured":"Hung N, Kang EYC, Lee TW, et al. The risks of corneal surface damage in aqueous-deficient dry eye disease: a 17-year population-based study in Taiwan. Am J Ophthalmol. 2021;227:231\u20139.","journal-title":"Am J Ophthalmol"},{"key":"3565_CR10","doi-asserted-by":"crossref","unstructured":"Pan L-Y, Kuo Y-K, Chen T-H, et al. Dry eye disease in patients with type II diabetes mellitus: a retrospective, population-based cohort study in Taiwan. Front Med (Lausanne). 2022;9:980714.","DOI":"10.3389\/fmed.2022.980714"},{"key":"3565_CR11","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.2147\/OPTH.S321591","volume":"15","author":"Z Al-Mohtaseb","year":"2021","unstructured":"Al-Mohtaseb Z, Schachter S, Lee BS, et al. The relationship between dry eye disease and digital screen use. Clin Ophthalmol (Auckland, NZ). 2021;15:3811.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"6","key":"3565_CR12","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/APO.0000000000000417","volume":"10","author":"L Tong","year":"2021","unstructured":"Tong L, Lim L, Tan D, et al. Assessment and management of dry eye disease and meibomian gland dysfunction: providing a Singapore framework. Asia-Pac J Ophthalmol (Philadelphia, PA). 2021;10(6):530.","journal-title":"Asia-Pac J Ophthalmol (Philadelphia, PA)"},{"issue":"3","key":"3565_CR13","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","volume":"15","author":"JAP Gomes","year":"2017","unstructured":"Gomes JAP, Azar DT, Baudouin C, et al. TFOS DEWS II iatrogenic report. Ocul Surf. 2017;15(3):511\u201338.","journal-title":"Ocul Surf"},{"issue":"3","key":"3565_CR14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones L, Downie LE, Korb D, Benitez-del-Castillo JM, Dana R, Deng SX, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575\u2013628.","journal-title":"Ocul Surf"},{"issue":"4","key":"3565_CR15","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/S2214-109X(20)30488-5","volume":"9","author":"MJ Burton","year":"2021","unstructured":"Burton MJ, Ramke J, Marques AP, et al. The Lancet global health commission on global eye health: Vision beyond 2020. Lancet Glob Health. 2021;9(4):e489\u2013551.","journal-title":"Lancet Glob Health"},{"issue":"12","key":"3565_CR16","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/ICO.0000000000001741","volume":"37","author":"R Sajnani","year":"2018","unstructured":"Sajnani R, Raia S, Gibbons A, et al. Epidemiology of persistent post-surgical pain manifesting as dry eye-like symptoms after cataract surgery. Cornea. 2018;37(12):1535.","journal-title":"Cornea"},{"issue":"1","key":"3565_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/ICU.0000000000000227","volume":"27","author":"C Sutu","year":"2016","unstructured":"Sutu C, Fukuoka H, Afshari NA. Mechanisms and management of dry eye in cataract surgery patients. Curr Opin Ophthalmol. 2016;27(1):24\u201330.","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"3565_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jtos.2016.04.005","volume":"14","author":"S Barabino","year":"2016","unstructured":"Barabino S, Labetoulle M, Rolando M, et al. Understanding symptoms and quality of life in patients with dry eye syndrome. Ocul Surf. 2016;14(3):365\u201376.","journal-title":"Ocul Surf"},{"key":"3565_CR19","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2147\/OPTH.S120159","volume":"11","author":"WB Trattler","year":"2017","unstructured":"Trattler WB, Majmudar PA, Donnenfeld ED, et al. The prospective health assessment of cataract patients\u2019 ocular surface (phaco) study: The effect of dry eye. Clin Ophthalmol (Auckland, NZ). 2017;11:1423.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"3565_CR20","doi-asserted-by":"crossref","unstructured":"Donthineni PR, Das AV, Shanbhag SS, et al. Cataract surgery in dry eye disease: visual outcomes and complications. Front Med (Lausanne). 2020;7:575834.","DOI":"10.3389\/fmed.2020.575834"},{"issue":"8","key":"3565_CR21","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jfo.2019.03.032","volume":"42","author":"M Labetoulle","year":"2019","unstructured":"Labetoulle M, Rousseau A, Baudouin C. Management of dry eye disease to optimize cataract surgery outcomes: two tables for a daily clinical practice. J Fr Ophtalmol. 2019;42(8):907\u201312.","journal-title":"J Fr Ophtalmol"},{"issue":"12","key":"3565_CR22","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.jcrs.2017.10.033","volume":"43","author":"J Chuang","year":"2017","unstructured":"Chuang J, Shih KC, Chan TC, et al. Preoperative optimization of ocular surface disease before cataract surgery. J Cataract Refract Surg. 2017;43(12):1596\u2013607.","journal-title":"J Cataract Refract Surg"},{"key":"3565_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2147\/OPTH.S281666","volume":"15","author":"MM Hantera","year":"2021","unstructured":"Hantera MM. Trends in dry eye disease management worldwide. Clin Ophthalmol (Auckland, NZ). 2021;15:165.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"5","key":"3565_CR24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/bjophthalmol-2017-310633","volume":"102","author":"ES Ong","year":"2018","unstructured":"Ong ES, Felix ER, Levitt RC, et al. Epidemiology of discordance between symptoms and signs of dry eye. Br J Ophthalmol. 2018;102(5):674\u20139.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"3565_CR25","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3390\/jcm8091439","volume":"8","author":"M Heidari","year":"2019","unstructured":"Heidari M, Noorizadeh F, Wu K, et al. Dry eye disease: emerging approaches to disease analysis and therapy. J Clin Med. 2019;8(9):1439.","journal-title":"J Clin Med"},{"issue":"1","key":"3565_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jtos.2016.09.003","volume":"15","author":"K Tsubota","year":"2017","unstructured":"Tsubota K, Yokoi N, Shimazaki J, et al. New perspectives on dry eye definition and diagnosis: a consensus report by the Asia Dry Eye Society. Ocul Surf. 2017;15(1):65\u201376.","journal-title":"Ocul Surf"},{"issue":"4","key":"3565_CR27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nelson JD, Azar DT, et al. TFOS DEWS II report executive summary. Ocul Surf. 2017;15(4):802\u201312.","journal-title":"Ocul Surf"},{"issue":"5","key":"3565_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jcrs.2019.03.023","volume":"45","author":"CE Starr","year":"2019","unstructured":"Starr CE, Gupta PK, Farid M, et al. An algorithm for the preoperative diagnosis and treatment of ocular surface disorders. J Cataract Refract Surg. 2019;45(5):669\u201384.","journal-title":"J Cataract Refract Surg"},{"key":"3565_CR29","first-page":"31","volume-title":"Asia-Pacific association of cataract and refractive surgeons","author":"L Li","year":"2017","unstructured":"Li L, Tong L, Yoon KC. Principles of preferred practice management of the ocular surface in cataract & refractive surgery. In: Asia-Pacific association of cataract and refractive surgeons. 2017. p. 31."},{"issue":"14","key":"3565_CR30","doi-asserted-by":"publisher","first-page":"DES7","DOI":"10.1167\/iovs.17-23475","volume":"59","author":"J Shimazaki","year":"2018","unstructured":"Shimazaki J. Definition and diagnostic criteria of dry eye disease: historical overview and future directions. Invest Ophthalmol Vis Sci. 2018;59(14):DES7\u201312.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3565_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276\u201383.","journal-title":"Ocul Surf"},{"issue":"3","key":"3565_CR32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539\u201374.","journal-title":"Ocul Surf"},{"issue":"1","key":"3565_CR33","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/ICL.0000000000000643","volume":"46","author":"K Tsubota","year":"2020","unstructured":"Tsubota K, Yokoi N, Watanabe H, et al. A new perspective on dry eye classification: proposal by the Asia Dry Eye Society. Eye Contact Lens. 2020;46(1):S2.","journal-title":"Eye Contact Lens"},{"issue":"9","key":"3565_CR34","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/bjophthalmol-2013-304619","volume":"98","author":"C Baudouin","year":"2014","unstructured":"Baudouin C, Aragona P, Van Setten G, et al. Diagnosing the severity of dry eye: a clear and practical algorithm. Br J Ophthalmol. 2014;98(9):1168\u201376.","journal-title":"Br J Ophthalmol"},{"key":"3565_CR35","doi-asserted-by":"crossref","unstructured":"Li Y, Smith RG, Steel JC, et al. Attitudes of eye health practitioners towards diagnostic tests and therapies for dry eye disease in Australasia. Cont Lens Anterior Eye. 2022;45(6):101724.","DOI":"10.1016\/j.clae.2022.101724"},{"issue":"6","key":"3565_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.31128\/AJGP-04-20-5318","volume":"50","author":"C Patel","year":"2021","unstructured":"Patel C, Supramaniam D. When the eyes are dry: an algorithm approach and management in general practice. Aust J Gen Pract. 2021;50(6):369\u201376.","journal-title":"Aust J Gen Pract."},{"issue":"14","key":"3565_CR37","doi-asserted-by":"publisher","first-page":"DES23","DOI":"10.1167\/iovs.18-24570","volume":"59","author":"A Shiraishi","year":"2018","unstructured":"Shiraishi A, Sakane Y. Assessment of dry eye symptoms: current trends and issues of dry eye questionnaires in Japan. Invest Ophthalmol Vis Sci. 2018;59(14):DES23\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"3565_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/diagnostics10080559","volume":"10","author":"Y Okumura","year":"2020","unstructured":"Okumura Y, Inomata T, Iwata N, et al. A review of dry eye questionnaires: measuring patient-reported outcomes and health-related quality of life. Diagnostics (Basel). 2020;10(8):559.","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"3565_CR39","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118(5):615\u201321.","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"3565_CR40","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1080\/02713683.2019.1604972","volume":"44","author":"M Yazdani","year":"2019","unstructured":"Yazdani M, Chen X, Tashbayev B, et al. Evaluation of the ocular surface disease index questionnaire as a discriminative test for clinical findings in dry eye disease patients. Curr Eye Res. 2019;44(9):941\u20137.","journal-title":"Curr Eye Res"},{"issue":"2","key":"3565_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clae.2009.12.010","volume":"33","author":"RL Chalmers","year":"2010","unstructured":"Chalmers RL, Begley CG, Caffery B. Validation of the 5-item dry eye questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses. Cont Lens Anterior Eye. 2010;33(2):55\u201360.","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"3565_CR42","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1001\/jamaophthalmol.2018.5243","volume":"137","author":"MT Wang","year":"2019","unstructured":"Wang MT, Xue AL, Craig JP. Comparative evaluation of 5 validated symptom questionnaires as screening instruments for dry eye disease. JAMA Ophthalmol. 2019;137(2):228\u20139.","journal-title":"JAMA Ophthalmol"},{"key":"3565_CR43","doi-asserted-by":"crossref","unstructured":"Akowuah PK, Adjei-Anang J, Nkansah EK, et al. Comparison of the performance of the dry eye questionnaire (DEQ-5) to the ocular surface disease index in a non-clinical population. Cont Lens Anterior Eye. 2022;45(3):101441.","DOI":"10.1016\/j.clae.2021.101441"},{"key":"3565_CR44","doi-asserted-by":"publisher","first-page":"2401213","DOI":"10.1155\/2018\/2401213","volume":"2018","author":"F Lu","year":"2018","unstructured":"Lu F, Tao A, Hu Y, et al. Evaluation of reliability and validity of three common dry eye questionnaires in Chinese. J Ophthalmol. 2018;2018:2401213.","journal-title":"J Ophthalmol"},{"issue":"6","key":"3565_CR45","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1159\/000525696","volume":"65","author":"Y Cai","year":"2022","unstructured":"Cai Y, Wei J, Zhou J, et al. Prevalence and incidence of dry eye disease in Asia: a systematic review and meta-analysis. Ophthalmic Res. 2022;65(6):647\u201358.","journal-title":"Ophthalmic Res"},{"issue":"2","key":"3565_CR46","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/eye.2017.289","volume":"32","author":"R Buckley","year":"2018","unstructured":"Buckley R. Assessment and management of dry eye disease. Eye. 2018;32(2):200\u20133.","journal-title":"Eye"},{"key":"3565_CR47","doi-asserted-by":"crossref","unstructured":"Kojima T, Dogru M, Kawashima M, et al. Advances in the diagnosis and treatment of dry eye. Prog Retin Eye Res. 2020:100842.","DOI":"10.1016\/j.preteyeres.2020.100842"},{"issue":"2","key":"3565_CR48","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jfo.2018.12.001","volume":"42","author":"A Herbaut","year":"2019","unstructured":"Herbaut A, Liang H, Denoyer A, et al. Tear film analysis and evaluation of optical quality: a review of the literature. J Fr Ophtalmol. 2019;42(2):e21\u201335.","journal-title":"J Fr Ophtalmol"},{"issue":"4","key":"3565_CR49","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.joco.2018.05.002","volume":"30","author":"S Kyei","year":"2018","unstructured":"Kyei S, Dzasimatu SK, Asiedu K, et al. Association between dry eye symptoms and signs. J Curr Ophthalmol. 2018;30(4):321\u20135.","journal-title":"J Curr Ophthalmol"},{"issue":"1","key":"3565_CR50","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/ICO.0000000000002148","volume":"39","author":"JR Paugh","year":"2020","unstructured":"Paugh JR, Tse J, Nguyen T, et al. Efficacy of the fluorescein tear breakup time (TBUT) test in dry eye. Cornea. 2020;39(1):92.","journal-title":"Cornea"},{"issue":"23","key":"3565_CR51","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1056\/NEJMra1407936","volume":"378","author":"JA Clayton","year":"2018","unstructured":"Clayton JA. Dry eye. N Engl J Med. 2018;378(23):2212\u201323.","journal-title":"N Engl J Med"},{"issue":"2","key":"3565_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/aos.12012","volume":"92","author":"BD Sullivan","year":"2014","unstructured":"Sullivan BD, Crews LA, Messmer EM, et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol. 2014;92(2):161\u20136.","journal-title":"Acta Ophthalmol"},{"key":"3565_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.12688\/f1000research.16468.1","volume":"7","author":"S Aggarwal","year":"2018","unstructured":"Aggarwal S, Galor A. What\u2019s new in dry eye disease diagnosis? Current advances and challenges. F1000Research. 2018;7:7.","journal-title":"F1000Research."},{"issue":"3","key":"3565_CR54","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jtos.2017.05.009","volume":"15","author":"GD Novack","year":"2017","unstructured":"Novack GD, Asbell P, Barabino S, et al. TFOS DEWS II clinical trial design report. Ocul Surf. 2017;15(3):629\u201349.","journal-title":"Ocul Surf"},{"issue":"3","key":"3565_CR55","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ophtha.2016.11.008","volume":"124","author":"J Vehof","year":"2017","unstructured":"Vehof J, Smitt-Kamminga NS, Nibourg SA, et al. Predictors of discordance between symptoms and signs in dry eye disease. Ophthalmology. 2017;124(3):280\u20136.","journal-title":"Ophthalmology"},{"key":"3565_CR56","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.2147\/OPTH.S89700","volume":"9","author":"JD Bartlett","year":"2015","unstructured":"Bartlett JD, Keith MS, Sudharshan L, et al. Associations between signs and symptoms of dry eye disease: a systematic review. Clin Ophthalmol (Auckland, NZ). 2015;9:1719.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"key":"3565_CR57","doi-asserted-by":"crossref","unstructured":"Asiedu K. Role of ocular surface neurobiology in neuronal-mediated inflammation in dry eye disease. Neuropeptides. 2022;95:102266.","DOI":"10.1016\/j.npep.2022.102266"},{"issue":"8","key":"3565_CR58","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3390\/jcm8081227","volume":"8","author":"Y-K Kuo","year":"2019","unstructured":"Kuo Y-K, Lin I-C, Chien L-N, et al. Dry eye disease: a review of epidemiology in Taiwan, and its clinical treatment and merits. J Clin Med. 2019;8(8):1227.","journal-title":"J Clin Med"},{"issue":"1","key":"3565_CR59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jtos.2017.09.007","volume":"16","author":"PE King-Smith","year":"2018","unstructured":"King-Smith PE, Begley CG, Braun RJ. Mechanisms, imaging and structure of tear film breakup. Ocul Surf. 2018;16(1):4\u201330.","journal-title":"Ocul Surf"},{"issue":"5","key":"3565_CR60","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/tvst.7.5.26","volume":"7","author":"S Karakus","year":"2018","unstructured":"Karakus S, Akpek EK, Agrawal D, et al. Validation of an objective measure of dry eye severity. Transl Vis Sci Technol. 2018;7(5):26.","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"3565_CR61","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1167\/tvst.8.6.34","volume":"8","author":"M Pellegrini","year":"2019","unstructured":"Pellegrini M, Bernabei F, Moscardelli F, et al. Assessment of corneal fluorescein staining in different dry eye subtypes using digital image analysis. Transl Vis Sci Technol. 2019;8(6):34.","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"3565_CR62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","volume":"5","author":"MA Lemp","year":"2007","unstructured":"Lemp MA, Foulks GN. The definition and classification of dry eye disease. Ocul Surf. 2007;5(2):75\u201392.","journal-title":"Ocul Surf"},{"issue":"3","key":"3565_CR63","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15(3):438\u2013510.","journal-title":"Ocul Surf"},{"issue":"1","key":"3565_CR64","first-page":"38","volume":"25","author":"TC Chan","year":"2019","unstructured":"Chan TC, Chow SS, Wan KH, et al. Update on the association between dry eye disease and meibomian gland dysfunction. Hong Kong Med J. 2019;25(1):38.","journal-title":"Hong Kong Med J"},{"issue":"2","key":"3565_CR65","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jtos.2017.01.006","volume":"15","author":"G Geerling","year":"2017","unstructured":"Geerling G, Baudouin C, Aragona P, et al. Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction: proceedings of the ocean group meeting. Ocular Surface. 2017;15(2):179\u201392.","journal-title":"Ocular Surface"},{"key":"3565_CR66","unstructured":"Brott NR, Zeppieri M, Ronquillo Y. Schirmer Test. 2024 Feb 24. In: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2024."},{"key":"3565_CR67","doi-asserted-by":"publisher","first-page":"21","DOI":"10.17925\/EOR.2019.13.1.21","volume":"13","author":"A Chiva","year":"2019","unstructured":"Chiva A. Tear biomarkers in dry eye disease. Eur Ophthal Rev. 2019;13:21\u20136.","journal-title":"Eur Ophthal Rev"},{"issue":"1","key":"3565_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-023-02931-3","volume":"23","author":"H Duan","year":"2023","unstructured":"Duan H, Yang T, Zhou Y, et al. Comparison of mucin levels at the ocular surface of visual display terminal users with and without dry eye disease. BMC Ophthalmol. 2023;23(1):1\u20138.","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"3565_CR69","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/APO.0000000000000417","volume":"10","author":"L Tong","year":"2021","unstructured":"Tong L, Lim L, Tan D, et al. Assessment and management of dry eye disease and meibomian gland dysfunction: Providing a Singapore framework. Asia Pac J Ophthalmol (Phila). 2021;10(6):530\u201341.","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"1","key":"3565_CR70","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jtos.2019.09.007","volume":"18","author":"A Hanyuda","year":"2020","unstructured":"Hanyuda A, Sawada N, Uchino M, et al. Physical inactivity, prolonged sedentary behaviors, and use of visual display terminals as potential risk factors for dry eye disease: JPHC- next study. Ocul Surf. 2020;18(1):56\u201363.","journal-title":"Ocul Surf"},{"issue":"3","key":"3565_CR71","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jtos.2019.05.007","volume":"17","author":"Y Jie","year":"2019","unstructured":"Jie Y, Sella R, Feng J, et al. Evaluation of incomplete blinking as a measurement of dry eye disease. Ocul Surf. 2019;17(3):440\u20136.","journal-title":"Ocul Surf"},{"issue":"10","key":"3565_CR72","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.4103\/ijo.IJO_3405_20","volume":"69","author":"D Ashwini","year":"2021","unstructured":"Ashwini D, Ramesh SV, Nosch D, et al. Efficacy of blink software in improving the blink rate and dry eye symptoms in visual display terminal users\u2013a single-blinded randomized control trial. Indian J Ophthalmol. 2021;69(10):2643.","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"3565_CR73","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/diagnostics11030392","volume":"11","author":"E Chlasta-Twardzik","year":"2021","unstructured":"Chlasta-Twardzik E, G\u00f3recka-Nito\u0144 A, Nowi\u0144ska A, et al. The influence of work environment factors on the ocular surface in a one-year follow-up prospective clinical study. Diagnostics (Basel). 2021;11(3):392.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"3565_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02713683.2021.1966476","volume":"47","author":"M Yazdani","year":"2022","unstructured":"Yazdani M, Elgst\u00f8en KBP, Utheim TP. Eye make-up products and dry eye disease: a mini review. Curr Eye Res. 2022;47(1):1\u201311.","journal-title":"Curr Eye Res"},{"key":"3565_CR75","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/OPTO.S150926","volume":"10","author":"MT Wang","year":"2018","unstructured":"Wang MT, Craig JP. Investigating the effect of eye cosmetics on the tear film: Current insights. Clin Opt. 2018;10:33\u201340.","journal-title":"Clin Opt"},{"key":"3565_CR76","doi-asserted-by":"crossref","unstructured":"Downie LE, Ng SM, Lindsley KB, et al. Omega\u20103 and omega\u20106 polyunsaturated fatty acids for dry eye disease. Cochrane Database Syst Rev. 2019;12(12):CD011016.","DOI":"10.1002\/14651858.CD011016.pub2"},{"issue":"8","key":"3565_CR77","doi-asserted-by":"publisher","first-page":"e677","DOI":"10.1111\/aos.13428","volume":"95","author":"I Molina-Leyva","year":"2017","unstructured":"Molina-Leyva I, Molina-Leyva A, Bueno-Cavanillas A. Efficacy of nutritional supplementation with omega-3 and omega-6 fatty acids in dry eye syndrome: a systematic review of randomized clinical trials. Acta Ophthalmol. 2017;95(8):e677\u201385.","journal-title":"Acta Ophthalmol"},{"key":"3565_CR78","doi-asserted-by":"crossref","unstructured":"Pucker AD, Ng SM, Nichols JJ. Over the counter (OTC) artificial tear drops for dry eye syndrome. Cochrane Database Syst Rev. 2016;2(2):CD009729.","DOI":"10.1002\/14651858.CD009729.pub2"},{"issue":"2","key":"3565_CR79","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/pharmaceutics13020207","volume":"13","author":"P Agarwal","year":"2021","unstructured":"Agarwal P, Craig JP, Rupenthal ID. Formulation considerations for the management of dry eye disease. Pharmaceutics. 2021;13(2):207.","journal-title":"Pharmaceutics"},{"key":"3565_CR80","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2147\/OPTH.S211611","volume":"13","author":"K Walsh","year":"2019","unstructured":"Walsh K, Jones L. The use of preservatives in dry eye drops. Clin Ophthalmol. 2019;13:1409\u201325.","journal-title":"Clin Ophthalmol"},{"issue":"8","key":"3565_CR81","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/aos.15159","volume":"100","author":"L Hynnekleiv","year":"2022","unstructured":"Hynnekleiv L, Magno M, Vernhardsdottir RR, et al. Hyaluronic acid in the treatment of dry eye disease. Acta Ophthalmol. 2022;100(8):844\u201360.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"3565_CR82","first-page":"56","volume":"9","author":"M Chen","year":"2020","unstructured":"Chen M, Choi SY. Preliminary outcomes of temporary collagen punctal plugs for patients with dry eye and glaucoma. Med Hypothesis Discov Innov Ophthalmol. 2020;9(1):56.","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"3565_CR83","doi-asserted-by":"crossref","unstructured":"Nagai N, Otake H. Novel drug delivery systems for the management of dry eye. Adv Drug Deliv Rev. 2022;191:114582.","DOI":"10.1016\/j.addr.2022.114582"},{"issue":"14","key":"3565_CR84","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.3390\/jcm11144019","volume":"11","author":"Y Wang","year":"2022","unstructured":"Wang Y, Ding Y, Jiang X, et al. Bacteria and dry eye: a narrative review. J Clin Med. 2022;11(14):4019.","journal-title":"J Clin Med"},{"key":"3565_CR85","first-page":"77","volume-title":"Ophthalmology secrets E-Book","author":"P Bhullar","year":"2022","unstructured":"Bhullar P, Venkateswaran N, Carlson AN, et al. Corneal infections. In: Ophthalmology secrets E-Book. 2022. p. 77."},{"issue":"6","key":"3565_CR86","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/APO.0000000000000331","volume":"9","author":"L Lim","year":"2020","unstructured":"Lim L, Lim EWL. Therapeutic contact lenses in the treatment of corneal and ocular surface diseases\u2014a review. Asia-Pac J Ophthalmol. 2020;9(6):524\u201332.","journal-title":"Asia-Pac J Ophthalmol"},{"issue":"1","key":"3565_CR87","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/2211-5056.369606","volume":"13","author":"A Nguyen","year":"2023","unstructured":"Nguyen A, Kolluru A, Beglarian T. Dry eye disease: a review of anti-inflammatory therapies. Taiwan J Ophthalmol. 2023;13(1):3.","journal-title":"Taiwan J Ophthalmol"},{"key":"3565_CR88","doi-asserted-by":"crossref","unstructured":"Liu S-H, Saldanha IJ, Abraham AG, et al. Topical corticosteroids for dry eye. Cochrane Database Syst Rev. 2022;10(10):CD015070.","DOI":"10.1002\/14651858.CD015070.pub2"},{"issue":"3","key":"3565_CR89","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/ICU.0000000000000569","volume":"30","author":"EC O\u2019Neil","year":"2019","unstructured":"O\u2019Neil EC, Henderson M, Massaro-Giordano M, et al. Advances in dry eye disease treatment. Curr Opin Ophthalmol. 2019;30(3):166.","journal-title":"Curr Opin Ophthalmol"},{"key":"3565_CR90","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jtos.2021.04.011","volume":"21","author":"JS Wolffsohn","year":"2021","unstructured":"Wolffsohn JS, Huarte ST, Jones L, et al. Clinical practice patterns in the management of dry eye disease: a TFOS international survey. Ocul Surf. 2021;21:78\u201386.","journal-title":"Ocul Surf"},{"key":"3565_CR91","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12325-019-01137-8","volume":"37","author":"M Kallab","year":"2020","unstructured":"Kallab M, Szegedi S, Hommer NS, et al. Topical low dose preservative-free hydrocortisone reduces signs and symptoms in patients with chronic dry eye: A randomized clinical trial. Adv Ther. 2020;37:329\u201341.","journal-title":"Adv Ther"},{"issue":"3","key":"3565_CR92","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/ICL.0000000000000879","volume":"48","author":"X Wang","year":"2022","unstructured":"Wang X, Jacobs DS. Contact lenses for ocular surface disease. Eye Contact Lens. 2022;48(3):115\u20138.","journal-title":"Eye Contact Lens"},{"key":"3565_CR93","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s40123-017-0100-z","volume":"6","author":"JL Alio","year":"2017","unstructured":"Alio JL, Rodriguez AE, Ferreira-Oliveira R, et al. Treatment of dry eye disease with autologous platelet-rich plasma: A prospective, interventional, non-randomized study. Ophthalmol Ther. 2017;6:285\u201393.","journal-title":"Ophthalmol Ther"},{"key":"3565_CR94","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fmed.2018.00033","volume":"5","author":"VJ Drew","year":"2018","unstructured":"Drew VJ, Tseng C-L, Seghatchian J, et al. Reflections on dry eye syndrome treatment: therapeutic role of blood products. Front Med (Lausanne). 2018;5:33.","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"3565_CR95","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4274\/tjo.69320","volume":"48","author":"C \u015eim\u015fek","year":"2018","unstructured":"\u015eim\u015fek C, Do\u011fru M, Kojima T, et al. Current management and treatment of dry eye disease. Turk J Ophthalmol. 2018;48(6):309.","journal-title":"Turk J Ophthalmol"},{"issue":"2","key":"3565_CR96","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s40123-018-0134-x","volume":"7","author":"RR Mesa","year":"2018","unstructured":"Mesa RR, Monteiro T. Continuous transitional focus (CTF): A new concept in ophthalmic surgery. Ophthalmol Therapy. 2018;7(2):223\u201331.","journal-title":"Ophthalmol Therapy"},{"key":"3565_CR97","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.yaoo.2021.04.020","volume":"6","author":"T Liu","year":"2021","unstructured":"Liu T, Shafer BM, Thompson V. Update on refractive surgery. Adv Ophthalmol Opt. 2021;6:325\u201339.","journal-title":"Adv Ophthalmol Opt"},{"issue":"5","key":"3565_CR98","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1177\/1120672120929958","volume":"30","author":"K Naderi","year":"2020","unstructured":"Naderi K, Gormley J, O\u2019Brart D. Cataract surgery and dry eye disease: a review. Eur J Ophthalmol. 2020;30(5):840\u201355.","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"3565_CR99","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s40123-022-00505-y","volume":"11","author":"B Schechter","year":"2022","unstructured":"Schechter B, Mah F. Optimization of the ocular surface through treatment of ocular surface disease before ophthalmic surgery: A narrative review. Ophthalmol Ther. 2022;11(3):1001\u201315.","journal-title":"Ophthalmol Ther"},{"issue":"4","key":"3565_CR100","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jtos.2020.08.005","volume":"18","author":"JP Craig","year":"2020","unstructured":"Craig JP, Wang MT, Ambler A, et al. Characterising the ocular surface and tear film in a population-based birth cohort of 45-year old New Zealand men and women. Ocul Surf. 2020;18(4):808\u201313.","journal-title":"Ocul Surf"},{"issue":"6","key":"3565_CR101","doi-asserted-by":"publisher","first-page":"55","DOI":"10.17116\/oftalma202113706155","volume":"137","author":"S Sakhnov","year":"2021","unstructured":"Sakhnov S, Yanchenko S, Malyshev A, et al. Ocular surface changes after cataract phacoemulsification. Vestn oftalmol. 2021;137(6):55\u201360.","journal-title":"Vestn oftalmol"},{"key":"3565_CR102","doi-asserted-by":"crossref","unstructured":"Siew L, Tong L. The effect of past cataract surgery within the medium to long-term period on patients with dry eye disease. J Clin Med. 2022;11(4).","DOI":"10.3390\/jcm11040972"},{"issue":"9","key":"3565_CR103","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jcrs.2018.06.026","volume":"44","author":"PK Gupta","year":"2018","unstructured":"Gupta PK, Drinkwater OJ, VanDusen KW, et al. Prevalence of ocular surface dysfunction in patients presenting for cataract surgery evaluation. J Cataract Refract Surg. 2018;44(9):1090\u20136.","journal-title":"J Cataract Refract Surg"},{"key":"3565_CR104","first-page":"1827","volume":"6","author":"RG Simpson","year":"2012","unstructured":"Simpson RG, Moshirfar M, Edmonds JN, et al. Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature. Clin Ophthalmol (Auckland, NZ). 2012;6:1827.","journal-title":"Clin Ophthalmol (Auckland, NZ)"},{"issue":"4","key":"3565_CR105","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/ICU.0000000000000668","volume":"31","author":"TY Chen","year":"2020","unstructured":"Chen TY, Chu DS. Refractive surgery for the patient with autoimmune diseases. Curr Opin Ophthalmol. 2020;31(4):247\u201352.","journal-title":"Curr Opin Ophthalmol"},{"issue":"12","key":"3565_CR106","first-page":"1","volume":"21","author":"JA Go","year":"2021","unstructured":"Go JA, Mamalis CA, Khandelwal SS. Cataract surgery considerations for diabetic patients. Curr DiabRep. 2021;21(12):1\u201310.","journal-title":"Curr DiabRep"},{"key":"3565_CR107","doi-asserted-by":"crossref","unstructured":"Jiang D, Xiao X, Fu T, et al. Transient tear film dysfunction after cataract surgery in diabetic patients. PLoS One. 2016;11(1).","DOI":"10.1371\/journal.pone.0146752"},{"key":"3565_CR108","unstructured":"Xian YP. Construction of risk model of dry eye after cataract surgery in type 2 diabetic patients.\u00a0Int Eye Sci. 2022;(12):623\u20138."},{"issue":"4","key":"3565_CR109","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s40123-022-00513-y","volume":"11","author":"M Miura","year":"2022","unstructured":"Miura M, Inomata T, Nakamura M, et al. Prevalence and characteristics of dry eye disease after cataract surgery: a systematic review and meta-analysis. Ophthalmol Ther. 2022;11(4):1309\u201332.","journal-title":"Ophthalmol Ther"},{"key":"3565_CR110","doi-asserted-by":"crossref","unstructured":"Nibandhe AS, Donthineni PR, editors. Understanding and optimizing ocular biometry for cataract surgery in dry eye disease: a review. In: Seminars in Ophthalmology. Taylor & Francis; 2022.","DOI":"10.1080\/08820538.2022.2112699"},{"issue":"3","key":"3565_CR111","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jcrs.2017.12.025","volume":"44","author":"F Chiambaretta","year":"2018","unstructured":"Chiambaretta F, Pleyer U, Behndig A, et al. Pupil dilation dynamics with an intracameral fixed combination of mydriatics and anesthetic during cataract surgery. J Cataract Refract Surg. 2018;44(3):341\u20137.","journal-title":"J Cataract Refract Surg"},{"key":"3565_CR112","doi-asserted-by":"crossref","unstructured":"Kanclerz P, Myers WG. Potential substitutes for povidone-iodine in ocular surgery. Nature Publishing Group; 2021. p. 2657\u20139.","DOI":"10.1038\/s41433-021-01447-8"},{"issue":"6","key":"3565_CR113","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.survophthal.2018.05.002","volume":"63","author":"JC Koerner","year":"2018","unstructured":"Koerner JC, George MJ, Meyer DR, et al. Povidone-iodine concentration and dosing in cataract surgery. Surv Ophthalmol. 2018;63(6):862\u20138.","journal-title":"Surv Ophthalmol"},{"key":"3565_CR114","unstructured":"Souki S. Qualitative and quantitative analysis of the impact of cataract surgery on the ocular surface. Diss. Universitat Autonoma de Barcelona; 2020. https:\/\/ddd.uab.cat\/record\/241094. Accessed 29 Aug 2023."},{"key":"3565_CR115","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s40123-020-00311-4","volume":"9","author":"RMEFG Scali","year":"2020","unstructured":"Scali RMEFG, Vignapiano R. Protecting the ocular surface at the time of cataract surgery: intracameral mydriatic and anaesthetic combination versus a standard topical protocol. Opthalmol Ther. 2020;9:1055\u201367.","journal-title":"Opthalmol Ther"},{"issue":"1","key":"3565_CR116","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.sjopt.2018.10.009","volume":"33","author":"S Ishrat","year":"2019","unstructured":"Ishrat S, Nema N, Chandravanshi S. Incidence and pattern of dry eye after cataract surgery. Saudi J Ophthalmol. 2019;33(1):34\u201340.","journal-title":"Saudi J Ophthalmol"},{"issue":"2","key":"3565_CR117","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40123-021-00332-7","volume":"10","author":"R Mencucci","year":"2021","unstructured":"Mencucci R, Vignapiano R, Rubino P, et al. Iatrogenic dry eye disease: dealing with the conundrum of post-cataract discomfort. A picasso board narrative review. Ophthalmol Ther. 2021;10(2):211\u201323.","journal-title":"Ophthalmol Ther."},{"key":"3565_CR118","doi-asserted-by":"crossref","unstructured":"Ben\u00edtez Mart\u00ednez M, Baeza Moyano D, Gonz\u00e1lez-Lezcano RA, editors. Phacoemulsification: proposals for improvement in its application. In: Healthcare. MDPI; 2021.","DOI":"10.3390\/healthcare9111603"},{"issue":"6","key":"3565_CR119","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s10792-018-0953-8","volume":"39","author":"P Kohli","year":"2019","unstructured":"Kohli P, Arya SK, Raj A, et al. Changes in ocular surface status after phacoemulsification in patients with senile cataract. Int Ophthalmol. 2019;39(6):1345\u201353.","journal-title":"Int Ophthalmol"},{"key":"3565_CR120","unstructured":"Miura M, Inomata T, Nakamura M, Sung J, et al. Prevalence and characteristics of dry eye disease after cataract surgery: a systematic review and meta-analysis. Ophthalmol Ther. 2022:1\u201324."},{"issue":"3","key":"3565_CR121","doi-asserted-by":"publisher","first-page":"133","DOI":"10.4274\/tjo.galenos.2019.45538","volume":"50","author":"P Garg","year":"2020","unstructured":"Garg P, Gupta A, Tandon N, et al. Dry eye disease after cataract surgery: study of its determinants and risk factors. Turk J Ophthalmol. 2020;50(3):133\u201342.","journal-title":"Turk J Ophthalmol"},{"issue":"1","key":"3565_CR122","doi-asserted-by":"publisher","first-page":"12659","DOI":"10.1038\/s41598-019-49159-0","volume":"9","author":"I Jun","year":"2019","unstructured":"Jun I, Choi S, Lee GY, et al. Effects of preservative-free 3% diquafosol in patients with pre-existing dry eye disease after cataract surgery: a randomized clinical trial. Sci Rep. 2019;9(1):12659.","journal-title":"Sci Rep"},{"key":"3565_CR123","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-3-030-94530-5_8","volume-title":"Cataract surgery : Advanced techniques for complex and complicated cases","author":"C Holtmann","year":"2022","unstructured":"Holtmann C, Geerling G. Cataract surgery in eyes with ocular surface problems and severe dry eye. In: Ali\u00f3 JL, Dick HB, Osher RH, editors. Cataract surgery\u202f: advanced techniques for complex and complicated cases. Cham: Springer International Publishing; 2022. p. 93\u2013104."},{"issue":"12","key":"3565_CR124","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.4103\/ijo.IJO_1957_20","volume":"68","author":"S D'Souza","year":"2020","unstructured":"D\u2019Souza S, James E, Swarup R, et al. Algorithmic approach to diagnosis and management of post-refractive surgery dry eye disease. Indian J Ophthalmol. 2020;68(12):2888.","journal-title":"Indian J Ophthalmol"},{"key":"3565_CR125","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/ICO.0000000000002125","volume":"38","author":"K Kato","year":"2019","unstructured":"Kato K, Miyake K, Hirano K, et al. Management of postoperative inflammation and dry eye after cataract surgery. Cornea. 2019;38:S25\u201333.","journal-title":"Cornea"},{"issue":"4","key":"3565_CR126","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.4103\/IJO.IJO_2807_22","volume":"71","author":"PR Donthineni","year":"2023","unstructured":"Donthineni PR, Deshmukh R, Ramamurthy C. Management of cataract in dry eye disease: Preferred practice pattern guidelines. Indian J Ophthalmol. 2023;71(4):1364\u201372.","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"3565_CR127","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ophtha.2018.12.044","volume":"126","author":"S Gupta","year":"2019","unstructured":"Gupta S, Ravindran RD, Subburaman GBB, et al. Evidence on importance of follow-up visits after cataract surgery. Ophthalmology. 2019;126(6):910\u20132.","journal-title":"Ophthalmology"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03565-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03565-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03565-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T09:08:36Z","timestamp":1722244116000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03565-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3565"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03565-9","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"16 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This report has been exempted from review in accordance with the policy of the Institutional Review Board of Chang Gung Memorial Hospital (IRB No. 202301652B1). It does not involve human subjects, data, or tissues, and no written informed consent was required by the Institutional Review Board of Chang Gung Memorial Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}